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ABSTRACT
Objective: The objective of this study is to investigate the attenuation of the nuclear factor-κ beta (NF-κB) and interleukin (IL)-6 expression in 
streptozotocin-induced diabetic rats by Sargassum polycystum methanol extract.
Methods: Diabetic rats were intraperitoneally induced by streptozotocin (40 mg/kg b.w.). S. polycystum methanol extract was administered to diabetic 
rats for 45 days. The effect of S. polycystum methanol extract on blood glucose, hemoglobin A1c (HbA1c), NF-κB, and IL-6 expression was investigated on 
streptozotocin-induced diabetic rats. The gliclazide (30 mg/kg b.w., p.o.) was used as a reference antidiabetic drug.
Results: The administration of S. polycystum methanol extract on streptozotocin-induced diabetic rats decreased the blood glucose level, HbA1c, 
NF-κB, and IL-6.
Conclusion: S. polycystum methanol extract indicates a promising anti-inflammation agent in diabetes.
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INTRODUCTION
Hyperglycemia can provoke inflammation, where the complications 
in diabetes are always initiated by this occurrence [1,2]. The 
inflammation on diabetes can be induced by the formation of 
advanced glycation end products, such as hemoglobin A1c (HbA1c) [3], 
and then the formation of these radicals elicits the nuclear factor-κ 
beta (NF-κB) activation. This cytokine can activate pro-inflammatory 
cytokines such as interleukin (IL)-6 [4]. The administration of oral 
hypoglycemic agents or insulin has been known to be able to control 
blood glucose and effective to prevent inflammation in diabetics. 
However, its use chronically stimulates the side effects [5]. Efforts 
must be taken, therefore, to discover and develop new hypoglycemic 
agents that do not coincide with inflammation.
Sargassum polycystum is a brown seaweed that grows in lower 
intertidal zones of warm tropical waters. This seaweed grows to 
a height of around 1–2 m, having erect branches and stems with 
numerous spines [6,7]. The methanol extract of this seaweed contains 
numerous phytochemical compounds such as steroids, alkaloids, 
phenolics, flavonoids, saponins, and sterols [8]. Previous studies had 
shown that the methanol extract of this seaweed is considered non-
toxic [9], having antioxidant activity [10], hypoglycemic action [11], 
and oxidative stress amelioration [12].
The evaluation of this brown seaweed methanol extract on the 
attenuation of inflammation in diabetes appears to lack information. 
Therefore, this study was undertaken to investigate the amelioration 




S. polycystum was collected from Talango coastline, Sumenep 
District, East Java, Indonesia, in March 2016. This seaweed was 
authenticated by AchmadKadi, the phycologist at the Research Center 
for Oceanography, Indonesian Institute of Sciences (Identification 
No. 498/IPK.2/LT.02.04/XII).
Preparation of extract
The collected sample was sun-dried, powdered by dish mill and 
passed through a sieve, and macerated by methanol (1:3; b/v) 
3 times for 24 h at 4°C. The extract was further concentrated to a 
semisolid form using a rotary vacuum evaporator, and then, it was 
flashed by nitrogen gas and finally freeze-dried by lyophilization to 
obtain the SPME.
Standard drug
Gliclazide tablets (Diamicron 30 MR, Servier, Laboratories Ltd.) are one 
of the group of sulfonylurea compounds used as the standard drug. This 
was purchased from Kimia Farma Pharmacy, Malang. The tablets were 
suspended in sesame oil and used for the experiment.
Animals
Male species of Rattus norvegicus strain Wistar with body weights ranging 
from 180 to 200 g were used in this study. The animal experiments were 
conducted according to the Institutional Ethics Committee of Animal 
Care and Use, Brawijaya University, Malang, Indonesia (No: 510-KEP-UB). 
The rats were acclimatized for 7 days before the study and housed in 
polypropylene cages under an ambient temperature. The rats were kept 
on a standard pellet diet and water ad libitum.
Induction of diabetes
Rats were induced diabetes by single intraperitoneal injection of 
streptozotocin (bioWORLD) (40 mg/kg) in fresh citrate buffer (pH=4.5) 
after overnight fasting. After 10 days of injection, rats showing blood 
glucose level >200 mg/dl were selected in the study and considered as 
diabetic, while the rats with a blood glucose <200 mg/dl were excluded 
from this study.
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Experimental design
Four groups of five rats each were distributed to the following 
treatments for 45 days - Group 1: Healthy normal rats received only 
sesame oil, Group 2: Diabetic control rats received only sesame 
oil, Group 3: Diabetic rats treated with gliclazide 30 mg/kg body 
weight/day orally, and Group 4: Diabetic rats treated with 600 mg/kg 
of SPME, respectively. The blood sample was obtained from the tails 
of rats. The blood glucose of rats was determined by glucometer 
(GlucoDr BioSensor AGM-2100) every 9 days during the experiment 
period. The blood of rats was acquired from the heart by puncture, 
and then, the serum was obtained by the centrifugation of the blood. 
The serum was stored at  −80°C until it was used for cytokines 
analysis.
HbA1c
HbA1c of serum was determined using Cobas Integra 400 Plus, Roche 
Diagnostics Ltd., Switzerland.
NF-κB and IL-6
NF-κB and IL-6 levels of serum were determined by ELISA kits 
(Bioassay Technology Laboratory No E0287Ra for NF-κB analysis and 
Bioassay Technology Laboratory No E0135Ra for IL-6 determination 
[Shanghai, China]), and the protocol of assay followed the manual of 
kits. The absorbance of the cytokine solutions was read using Bio-Rad 
Model 680 microplate reader.
Statistical analysis
Data of this study were stated as mean±standard error mean. The 
difference among treatments was analyzed by the analysis of variance 
and followed by the least square difference test. The significance level 
was set at p<0.05.
RESULTS
Effect of SPME on blood glucose in streptozotocin-induced diabetic 
rats
The effect of SPME on blood glucose in streptozotocin-induced 
diabetic rats is shown in Table 1. This study showed the SPME 
treatments on diabetic rats significantly reduced the blood glucose 
level after the 18th day compared to the diabetic control. Diabetic 
control showed a significant increase in the blood glucose when 
compared to normal.
Effect of SPME on HbA1c levels in streptozotocin-induced diabetic 
rats
Table 2 shows that SPME diminished significantly on the HbA1c level 
of streptozotocin-induced diabetic rats when compared to diabetic 
control. The HbA1c level on diabetic rats was diminished by the SPME 
treatments. Diabetic control exhibited the highest level of the HbA1c 
among other treatments.
Effect of SPME on NF-κB and IL-6 levels in streptozotocin-induced 
diabetic rats
The decrease of NF-κB and IL-6 expression in streptozotocin-induced 
diabetic rats was affected by SPME (Table 2). The expression of 
NF-κB and IL-6 on diabetic rats was reduced by gliclazide as well. The 
inflammation level on diabetic control showed the strongest level 
compared to other treatments.
DISCUSSION
The blood glucose level of diabetic rats was higher than normal. The 
treatment of streptozotocin injection causes hyperglycemia on the 
normal rats [13]. Usage of gliclazide reduced the blood glucose level 
on the diabetic rats by enhancing insulin secretion. The blood glucose 
of diabetic rats which were treated with SPME showed a decrease. 
Phenolics in SPME reveal the insulin-mimicking effect [14], so the blood 
glucose level in diabetic rats decreased.
Hyperglycemia in diabetic rats caused the increase in advanced 
glycation end products formation, such as HbA1c [15]. The hypoglycemic 
capability of gliclazide affected this Hb level in diabetic rats. This drug 
is also able to eliminate the free radical, so the production of this 
glycation product will decrease. SPME contains phenolics, where these 
compounds are capable as insulin-mimicking and antioxidant agents. 
The importance of these activities is the inhibition and reduction of 
glycation product in the Hb [16].
Inflammation can be induced by high blood glucose in diabetics. The 
NF-κB and IL-6 expression in the diabetic rats was the highest among 
the other treatments. Gliclazide belongs to insulin secretagogues, so the 
blood glucose level of diabetics decreased. This reduction will diminish 
the inflammation in diabetics. The diabetic rats treated with SPME 
showed the decrease of NF-κB and IL-6 expressions. These phenomena 
can be affected by the decrease of blood glucose by SPME in diabetic 
rats, where one of the inflammation causes in diabetes is hyperglycemia.
Thus, the present study proves that the S. polycystum methanol extract 
exhibits potency and demonstrates the prevention of inflammation in 
diabetes.
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Table 1: Effect of SPME on blood glucose in streptozotocin-induced diabetic rats
Groups Mean blood glucose level in mg/dl at different time intervals
Treatment (mg/kg) 0 day 9th day 18th day 27th day 36th day 45th day
Normal control Sesame oil, p.o. 119.8±8.2 118±8.1 118.4±8.4 121.2±8.8 112.48.0 114.0±7.9
Diabetic control Sesame oil, p.o. 503.0±17.4* 506.0±16.9* 538.2±18.2* 545.4±17.8* 556.8±13.8* 566.8±13.9*
Gliclazide 30, p.o. 519.4±21.9* 512.4±19.6* 406.8±15.2*† 250.8±10.8*† 205.4±8.5*† 176.0±6.6*†
SPME 600, p.o. 507.4±19.2* 494.2±17.8* 454.6±16.5*† 363.4±14.4*† 280.8±10.7*† 206.4±7.5*†
Data were expressed as mean±SEM, (n=5). *p<0.05 versus NC, †p<0.05 versus DC. SEM: Standard error of the mean
Table 2: Effect of SPME on HbA1c, NF-kB, and IL-6 in 
streptozotocin-induced diabetic rats
Groups Treatment HbA1c NF-κB IL-6
(mg/kg) (%) (ηg/ml) (ρg/ml)
Normal 
control
Sesame oil, p.o. 5.37±0.10 1.5±0.03 13.6±0.51
Diabetic 
control
Sesame oil, p.o. 16.65±0.31* 4.8±0.08* 81.8±3.04*
Gliclazide 30, p.o. 7.11±0.13*† 2.3±0.04*† 24.6±0.93*†
SPME 600, p.o. 9.09±0.17*† 3.8±0.07*† 43.4±1.61*†
Data were expressed as mean±SEM, (n=5). *p<0.05 versus NC, †p<0.05 versus 
DC. HbA1c: Hemoglobin A1c, NF-kB: Nuclear factor-k beta, IL: Interleukin, 
SEM: Standard error of the mean
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